Skip to main content
. Author manuscript; available in PMC: 2013 Jul 15.
Published in final edited form as: Anticancer Res. 2011 Nov;31(11):3673–3681.

Figure 1.

Figure 1

CDDO-Me inhibits the growth of ovarian cancer cells. A: Ovarian cancer cells (OVCAR-5, MDAH-2774, OVCAR-3 and SK-OV3) were treated with CDDO-Me at concentrations ranging from 0 to 20 μM for 72 h in triplicate in 96-well plates. Cell viability was measured by MTS assay using CellTiter AQueous Assay System. B: Morphological changes in cell cultures of OVCAR-5 and MDAH-2774 cells treated or not with CDDO-Me for 48 h as visualized by light microscopy. Similar results were obtained in three independent experiments. *p<0.05 compared to control cells (no CDDO-Me).